|
|
Other links at Articles > Cardiology |
| 2. |
New Torcetrapib Data Rejuvenate Interest in Other CETP Inhibitors
|
|
|
New data from the ILLUMINATE and ILLUSTRATE trials have shown that torcetrapib stimulates aldosterone, which possibly accounts for its adverse outcomes. In addition, both studies showed that patients with the largest HDL increases with the drug showed benefits, suggesting that the HDL produced was functional. Heartwire
|
|
|
